Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Head and Neck Cancer

Free Subscription 25.02.2019 3 Clin Nucl Med 4 Dis Esophagus 2 Gastrointest Endosc 7 Head Neck 1 Hum Pathol 2 Int J Radiat Oncol Biol Phys 3 J Oral Maxillofac Surg 1 Laryngoscope 2 Oral Oncol 5 PLoS One 1 Radiother Oncol

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Clin Nucl Med

1. SHAO F, Zhou D, Lan X
   Increased 99mTc Pertechnetate Uptake But Unimpressive 131I Activity in the Metastatic Mediastinal Lymph Nodes in a Thyroid Cancer Patient.
   Clin Nucl Med. 2018 Dec 3. doi: 10.1097/RLU.0000000000002405.
   PubMed     Text format     Abstract available
   
   
2. SINGH H, Wale DJ, Wong KK, Gross MD, et al
   Synchronous Metastatic Breast Carcinoma and Parathyroid Adenoma on 18F-FDG PET/CT and 99mTc-Sestamibi Imaging.
   Clin Nucl Med. 2018 Nov 10. doi: 10.1097/RLU.0000000000002380.
   PubMed     Text format     Abstract available
   
   
3. RIES M, Khreish F, Veith C, von den Hoff J, et al
   Large Paraesophageal Schwannoma With Intense Prostate-Specific Membrane Antigen Expression on 68Ga-PSMA-PET/CT Mimicking Lymph Node Metastasis in a Patient With Prostate Cancer.
   Clin Nucl Med. 2018 Oct 27. doi: 10.1097/RLU.0000000000002359.
   PubMed     Text format     Abstract available
   
   

   
   Dis Esophagus

4. MINE S, Watanabe M, Kumagai K, Okamura A, et al
   Comparison of mediastinal lymph node metastases from adenocarcinoma of the esophagogastric junction versus lower esophageal squamous cell carcinoma with involvement of the esophagogastric junction.
   Dis Esophagus. 2019 Feb 22. pii: 5355647. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   
5. SEESING MFJ, Scheijmans JCG, Borggreve AS, van Hillegersberg R, et al
   The predictive value of new-onset atrial fibrillation on postoperative morbidity after esophagectomy.
   Dis Esophagus. 2018;31.
   PubMed     Text format     Abstract available
   
   
6. ELURI S, Klaver E, Duits LC, Jackson SA, et al
   Validation of a biomarker panel in Barrett's esophagus to predict progression to esophageal adenocarcinoma.
   Dis Esophagus. 2018;31.
   PubMed     Text format     Abstract available
   
   
7. SAWAS T, Visrodia KH, Zakko L, Lutzke LS, et al
   Clutch cutter is a safe device for performing endoscopic submucosal dissection of superficial esophageal neoplasms: a western experience.
   Dis Esophagus. 2018;31.
   PubMed     Text format     Abstract available
   
   

   
   Gastrointest Endosc

8. DAVISON JM, Shah MB, Deitrick C, Chennat J, et al
   Low-grade dysplasia diagnosis ratio and progression metrics identify variable Barrett's esophagus risk stratification proficiency in independent pathology practices.
   Gastrointest Endosc. 2018;88:807-815.
   PubMed     Text format     Abstract available
   
   
9. VAN MUNSTER SN, Overwater A, Haidry R, Bisschops R, et al
   Focal cryoballoon versus radiofrequency ablation of dysplastic Barrett's esophagus: impact on treatment response and postprocedural pain.
   Gastrointest Endosc. 2018;88:795-803.
   PubMed     Text format     Abstract available
   
   

   
   Head Neck

10. WANG B, Weng YJ, Wang SS, Zhao WX, et al
    Feasibility and safety of needle-assisted endoscopic thyroidectomy with lateral neck dissection for papillary thyroid carcinoma: a preliminary experience.
    Head Neck. 2019 Feb 18. doi: 10.1002/hed.25705.
    PubMed     Text format     Abstract available
    
    
11. SHAHA AR
    Recent historic perspective on modified neck dissection.
    Head Neck. 2019 Feb 18. doi: 10.1002/hed.25700.
    PubMed     Text format    
    
    
12. TASSLER AB, Gooding WE, Ferris RL
    Hypopharyngeal cancer treatment: Does initial surgery confer survival benefit?
    Head Neck. 2019 Feb 19. doi: 10.1002/hed.25687.
    PubMed     Text format     Abstract available
    
    
13. WALD P, Grecula J, Walston S, Wei L, et al
    Intraoperative electron beam radiotherapy for locoregionally persistent or recurrent head and neck cancer.
    Head Neck. 2019 Feb 19. doi: 10.1002/hed.25673.
    PubMed     Text format     Abstract available
    
    
14. BATES JE, De Leo AN, Morris CG, Amdur RJ, et al
    Oligometastatic squamous cell carcinoma of the head and neck treated with stereotactic body ablative radiotherapy: Single-institution outcomes.
    Head Neck. 2019 Feb 20. doi: 10.1002/hed.25695.
    PubMed     Text format     Abstract available
    
    
15. SMEE R, Williams JR, Kotevski DP
    Surgery is not the only determinant of an outcome in patients with hypopharyngeal carcinoma.
    Head Neck. 2019 Feb 21. doi: 10.1002/hed.25496.
    PubMed     Text format     Abstract available
    
    
16. VAN DEN STEEN L, Van Gestel D, Vanderveken O, Vanderwegen J, et al
    Evolution of self-perceived swallowing function, tongue strength and swallow-related quality of life during radiotherapy in head and neck cancer patients.
    Head Neck. 2019 Feb 14. doi: 10.1002/hed.25684.
    PubMed     Text format     Abstract available
    
    

    
    Hum Pathol

17. ISLAM F, Gopalan V, Law S, Tang JC, et al
    FAM134B promotes esophageal squamous cell carcinoma in vitro and its correlations with clinicopathologic features.
    Hum Pathol. 2019 Feb 19. pii: S0046-8177(19)30019.
    PubMed     Text format     Abstract available
    
    

    
    Int J Radiat Oncol Biol Phys

18. BOURGIER C, Auperin A, Rivera S, Boisselier P, et al
    Pravastatin Reverses Established Radiation-Induced Cutaneous and Subcutaneous Fibrosis in Patients with Head and Neck Cancer: Results of the Biology-Driven Phase Ii Clinical Trial Pravacur.
    Int J Radiat Oncol Biol Phys. 2019 Feb 15. pii: S0360-3016(19)30250.
    PubMed     Text format     Abstract available
    
    
19. SHURYAK I, Hall EJ, Brenner DJ
    Optimized Hypofractionation can Markedly Improve Tumor Control and Decrease Late Effects for Head and Neck Cancer.
    Int J Radiat Oncol Biol Phys. 2019 Feb 15. pii: S0360-3016(19)30251.
    PubMed     Text format     Abstract available
    
    

    
    J Oral Maxillofac Surg

20. KANE G, Petrosyan V, Ameerally P
    Oral Cancer Treatment Through the Ages: Part 1.
    J Oral Maxillofac Surg. 2019 Jan 28. pii: S0278-2391(19)30098.
    PubMed     Text format     Abstract available
    
    
21. PETROSYAN V, Kane G, Ameerally P
    Oral Cancer Treatment Through the Ages: Part 2.
    J Oral Maxillofac Surg. 2019 Jan 28. pii: S0278-2391(19)30099.
    PubMed     Text format     Abstract available
    
    
22. ZHANG C, Xi MY, Zeng J, Li Y, et al
    Prognostic Impact of Postoperative Complications on Overall Survival in 287 Patients With Oral Cancer: A Retrospective Single-Institution Study.
    J Oral Maxillofac Surg. 2019 Jan 26. pii: S0278-2391(19)30095.
    PubMed     Text format     Abstract available
    
    

    
    Laryngoscope

23. RENDA L, Tsai TY, Huang JJ, Ito R, et al
    A nomogram to predict osteoradionecrosis in oral cancer after marginal mandibulectomy and radiotherapy.
    Laryngoscope. 2019 Feb 20. doi: 10.1002/lary.27870.
    PubMed     Text format     Abstract available
    
    

    
    Oral Oncol

24. SALEH K, Saada E, Auger N, Mayache-Badis L, et al
    Successful treatment with trastuzumab in HER2-positive squamous cell carcinoma of the head and neck.
    Oral Oncol. 2019 Feb 14. pii: S1368-8375(19)30044.
    PubMed     Text format    
    
    
25. YU ST, Xiao ZZ
    Letter to the Editor regarding, "Total thyroidectomy versus lobectomy for intermediate-risk papillary thyroid carcinoma: A single-institution matched-pair analysis".
    Oral Oncol. 2019 Feb 14. pii: S1368-8375(19)30045.
    PubMed     Text format    
    
    

    
    PLoS One

26. REZAPOUR A, Jahangiri R, Olyaeemanesh A, Kalaghchi B, et al
    The economic burden of oral cancer in Iran.
    PLoS One. 2018;13:e0203059.
    PubMed     Text format     Abstract available
    
    
27. LOHSE I, Al-Ali H, Volmar CH, D Alvarez Trotta A, et al
    Ex vivo drug sensitivity testing as a means for drug repurposing in esophageal adenocarcinoma.
    PLoS One. 2018;13:e0203173.
    PubMed     Text format     Abstract available
    
    
28. PARK YM, Go YY, Shin SH, Cho JG, et al
    Anti-cancer effects of disulfiram in head and neck squamous cell carcinoma via autophagic cell death.
    PLoS One. 2018;13:e0203069.
    PubMed     Text format     Abstract available
    
    
29. CHO JK, Lee GJ, Kim HD, Moon UY, et al
    Differential impact of circulating tumor cells on disease recurrence and survivals in patients with head and neck squamous cell carcinomas: An updated meta-analysis.
    PLoS One. 2018;13:e0203758.
    PubMed     Text format     Abstract available
    
    
30. MEYER HJ, Purz S, Sabri O, Surov A, et al
    Relationships between histogram analysis of ADC values and complex 18F-FDG-PET parameters in head and neck squamous cell carcinoma.
    PLoS One. 2018;13:e0202897.
    PubMed     Text format     Abstract available
    
    

    
    Radiother Oncol

31. WAN Y, Tian L, Zhang G, Xin H, et al
    The value of detailed MR imaging report of primary tumor and lymph nodes on prognostic nomograms for nasopharyngeal carcinoma after intensity-modulated radiotherapy.
    Radiother Oncol. 2019;131:35-44.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Head and Neck Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: